{
  "symbol": "AAREYDRUGS.NS",
  "period": "annual",
  "data": [
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2022-03-31",
      "quarter": "Q1 2022",
      "fiscal_year": 2022,
      "revenue": 4916097000.0,
      "gross_profit": 195548000.0,
      "operating_income": 94875000.0,
      "ebitda": 139377000.0,
      "net_income": 65548000.0,
      "diluted_eps": null,
      "total_assets": 2451688000.0,
      "total_liabilities": 1315315000.0,
      "total_equity": 1136373000.0,
      "total_debt": 141625000.0,
      "cash_and_equivalents": 1919000.0,
      "current_assets": 2188169000.0,
      "current_liabilities": 1267362000.0,
      "operating_cash_flow": 4988000.0,
      "investing_cash_flow": -32100000.0,
      "financing_cash_flow": 22534000.0,
      "free_cash_flow": -17025000.0,
      "capex": -22013000.0,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": 0.124628973057262,
      "current_ratio": 1.7265540548004437,
      "operating_margin": 1.9298846218860206,
      "net_profit_margin": 1.3333341469869289,
      "roe": 5.768176470225885,
      "roa": 2.673586524875922,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 2.835114929587435,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2023-03-31",
      "quarter": "Q1 2023",
      "fiscal_year": 2023,
      "revenue": 4128498000.0,
      "gross_profit": 90091000.0,
      "operating_income": 20047000.0,
      "ebitda": 101941000.0,
      "net_income": 37711000.0,
      "diluted_eps": null,
      "total_assets": 2913245000.0,
      "total_liabilities": 1739161000.0,
      "total_equity": 1174084000.0,
      "total_debt": 377181000.0,
      "cash_and_equivalents": 7058000.0,
      "current_assets": 2706058000.0,
      "current_liabilities": 1681405000.0,
      "operating_cash_flow": -12811000.0,
      "investing_cash_flow": 4410000.0,
      "financing_cash_flow": 13540000.0,
      "free_cash_flow": -23251000.0,
      "capex": -10440000.0,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": 0.32125554900671505,
      "current_ratio": 1.609402850592213,
      "operating_margin": 0.48557611024638986,
      "net_profit_margin": 0.9134314707188909,
      "roe": 3.211950763318468,
      "roa": 1.2944671663385674,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 2.469203085480482,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2024-03-31",
      "quarter": "Q1 2024",
      "fiscal_year": 2024,
      "revenue": 3951029000.0,
      "gross_profit": 132043000.0,
      "operating_income": 28246000.0,
      "ebitda": 113509000.0,
      "net_income": 46837000.0,
      "diluted_eps": null,
      "total_assets": 3032941000.0,
      "total_liabilities": 1705385000.0,
      "total_equity": 1327556000.0,
      "total_debt": 313524000.0,
      "cash_and_equivalents": 15944000.0,
      "current_assets": 2825869000.0,
      "current_liabilities": 1665469000.0,
      "operating_cash_flow": -29938000.0,
      "investing_cash_flow": -17023000.0,
      "financing_cash_flow": 55848000.0,
      "free_cash_flow": -37161000.0,
      "capex": -7223000.0,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": 0.2361663086152298,
      "current_ratio": 1.6967406778511038,
      "operating_margin": 0.714902371002592,
      "net_profit_margin": 1.1854380213357079,
      "roe": 3.528062093049182,
      "roa": 1.5442766608384404,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 2.87289716172673,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AAREYDRUGS.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 4722350000.0,
      "gross_profit": 101738000.0,
      "operating_income": 8084000.0,
      "ebitda": 119291000.0,
      "net_income": 40239000.0,
      "diluted_eps": null,
      "total_assets": 2905920000.0,
      "total_liabilities": 1521115000.0,
      "total_equity": 1384805000.0,
      "total_debt": 348560000.0,
      "cash_and_equivalents": 14733000.0,
      "current_assets": 2656190000.0,
      "current_liabilities": 1492061000.0,
      "operating_cash_flow": 103004000.0,
      "investing_cash_flow": -59394000.0,
      "financing_cash_flow": -44821000.0,
      "free_cash_flow": 50960000.0,
      "capex": -52044000.0,
      "pe_ratio": 54.4,
      "peg_ratio": null,
      "pb_ratio": 1.2816163,
      "ps_ratio": 0.45021734,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.50565,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": 28354303,
      "debt_to_equity": 0.251703308408043,
      "current_ratio": 1.7802154201470315,
      "operating_margin": 0.1711859561447161,
      "net_profit_margin": 0.8520969432591823,
      "roe": 2.9057520733966156,
      "roa": 1.384724975222993,
      "debt_to_fcf_ratio": 6.839874411302983,
      "ebitda_margin": 2.526093999809417,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    }
  ]
}